Abstract
The authors investigate the development of Taiwan’s bio-pharmaceutical industry through six factors: Institutions, demand, learning processes and technologies, Actor and networks, human resource and market. Most companies agree that government does improve the infrastructure and now most of the R&D products are from in-house research. In addition, most of the fund and R&D workers are recruited from Taiwan not abroad but it is still a difficult position to hire good R&D in Taiwan. As a result of that, enterprises have their own training programs and are willing to attend to relative programs provided by government. We also found that Taiwan bio-pharmaceutical fields prefer in-house research and cooperate with government science projects rather that co-work within the firms that show networking is still weak and not be reliable. Another issue for commercialization is lacking in channels to entry international market and build up marketing approach.